Market Closed -
Hong Kong S.E.
04:08:20 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
10.34
HKD
|
+0.98%
|
|
+11.54%
|
-16.88%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
6,907
|
3,769
|
3,134
|
3,134
|
-
|
Enterprise Value (EV)
1 |
3,987
|
2,578
|
3,704
|
2,140
|
2,124
|
P/E ratio
|
-
|
-33.4
x
|
-47.1
x
|
43.5
x
|
19.7
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
38.8
x
|
11.3
x
|
7.02
x
|
4.1
x
|
2.88
x
|
EV / Revenue
|
22.4
x
|
7.72
x
|
7.02
x
|
2.8
x
|
1.95
x
|
EV / EBITDA
|
-19.4
x
|
-13
x
|
-44
x
|
28.2
x
|
13.5
x
|
EV / FCF
|
-
|
-11.4
x
|
-8.09
x
|
-14.7
x
|
-33.2
x
|
FCF Yield
|
-
|
-8.77%
|
-12.4%
|
-6.82%
|
-3.01%
|
Price to Book
|
1.95
x
|
1.21
x
|
1.03
x
|
1.03
x
|
0.97
x
|
Nbr of stocks (in thousands)
|
332,401
|
332,401
|
327,458
|
327,458
|
-
|
Reference price
2 |
20.78
|
11.34
|
9.571
|
9.571
|
9.571
|
Announcement Date
|
3/15/22
|
3/29/23
|
3/21/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
27.63
|
177.9
|
334.1
|
527.8
|
763.6
|
1,087
|
EBITDA
1 |
-
|
-205.9
|
-198
|
-47.4
|
76
|
157.2
|
EBIT
1 |
-
|
-212.5
|
-208.4
|
-156.5
|
51
|
160.5
|
Operating Margin
|
-
|
-119.43%
|
-62.38%
|
-29.66%
|
6.68%
|
14.76%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-113.6
|
-78.73
|
76.33
|
171.3
|
Net income
1 |
-
|
-
|
-113.6
|
-78.73
|
72
|
161.3
|
Net margin
|
-
|
-
|
-33.99%
|
-14.92%
|
9.43%
|
14.84%
|
EPS
2 |
-0.5200
|
-
|
-0.3400
|
-0.2400
|
0.2200
|
0.4867
|
Free Cash Flow
1 |
-
|
-
|
-226.1
|
-258
|
-146
|
-64
|
FCF margin
|
-
|
-
|
-67.66%
|
-51.16%
|
-19.12%
|
-5.89%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/22/21
|
3/15/22
|
3/29/23
|
3/21/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
2,919
|
1,191
|
1,046
|
994
|
1,011
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-226
|
-258
|
-146
|
-64
|
ROE (net income / shareholders' equity)
|
-
|
-11.2%
|
-3.64%
|
0.09%
|
2.33%
|
4.72%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-3.49%
|
-0.57%
|
2.1%
|
4.37%
|
Assets
1 |
-
|
-
|
3,251
|
3,294
|
3,429
|
3,695
|
Book Value Per Share
2 |
-
|
10.70
|
9.370
|
9.320
|
9.340
|
9.870
|
Cash Flow per Share
2 |
-
|
-
|
-0.2800
|
0.0500
|
0.1200
|
0.3300
|
Capex
1 |
-
|
-
|
135
|
118
|
98.3
|
99.7
|
Capex / Sales
|
-
|
-
|
40.33%
|
23.33%
|
12.88%
|
9.17%
|
Announcement Date
|
6/22/21
|
3/15/22
|
3/29/23
|
3/21/24
|
-
|
-
|
Last Close Price
9.571
CNY Average target price
14.11
CNY Spread / Average Target +47.39% Consensus |
1st Jan change
|
Capi.
|
---|
| -16.88% | 433M | | +12.07% | 128B | | -9.04% | 10.65B | | +0.91% | 8.82B | | +16.72% | 7.19B | | +25.15% | 4.99B | | +7.17% | 3.4B | | -1.36% | 3.03B | | -8.73% | 2.14B | | -10.15% | 2B |
Medical Devices & Implants
|